nach oben

Erschienen in:

17.06.2020

Antenatal Admissions Among Women with Opioid-Affected and Non-Opioid-Affected Deliveries

verfasst von: Laura J. Faherty, Ashley M. Kranz, Joshua Russell-Fritch, Teague Ruder, Stephen W. Patrick, Bradley D. Stein

Erschienen in: Maternal and Child Health Journal | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

(1) To compare the prevalence of antenatal admissions and mean length of stay among women with opioid-affected and non-opioid-affected deliveries; (2) examine predictors of admission; and (3) describe the most common discharge diagnoses in each group.

Methods

Using data from seven states in the State Inpatient Databases for varying years between 2009 and 2014, delivery hospitalizations among women 18 years of age and older were identified and classified as opioid-affected or non-opioid-affected. Antenatal admissions were linked to deliveries. The antenatal admission ratio and mean length of stay for each group were calculated; the percentage of deliveries in each group with no, any, one, two, or three or more antenatal admissions were compared with t-tests. Logistic regression models estimated odds of any antenatal admission, stratified by opioid-affected and non-opioid-affected deliveries. Frequencies were tabulated for the ten most common discharge diagnoses in each group.

Results

Of 2,684,970 deliveries, 14,765 were opioid-affected. Admissions among women with opioid-affected deliveries were more prevalent (26.4 per 100 deliveries) compared to 6.7 among women with non-opioid-affected deliveries and were associated with a 1.5-day longer mean length of stay. The presence of a behavioral health condition was associated with higher odds of antenatal admission in both groups, with a particularly strong association among women with opioid-affected deliveries. Six of the ten most common diagnoses for admissions prior to opioid-affected deliveries were behavioral health-related.

Conclusions for Practice

These results highlight the importance of addressing the large burden of behavioral health conditions among pregnant women, especially those with opioid dependence and abuse.

Nur mit Berechtigung zugänglich

Adams, M. M., Harlass, F. E., Sarno, A. P., Read, J. A., & Rawlings, J. S. (1994). Antenatal hospitalization among enlisted servicewomen, 1987–1990. Obstetrics and Gynecology, 84(1), 35–39.PubMed

Admon, L. K., Winkelman, T. N. A., Heisler, M., & Dalton, V. K. (2018a). Obstetric outcomes and delivery-related health care utilization and costs among pregnant women with multiple chronic conditions. Preventing Chronic Disease, 15, E21. https://doi.org/10.5888/pcd15.170397.PubMedPubMedCentralCrossRef

Admon, L. K., Winkelman, T. N. A., Moniz, M. H., Davis, M. M., Heisler, M., & Dalton, V. K. (2017). Disparities in chronic conditions among women hospitalized for delivery in the United States, 2005–2014. Obstetrics and Gynecology, 130(6), 1319–1326. https://doi.org/10.1097/AOG.0000000000002357.PubMedPubMedCentralCrossRef

Admon, L. K., Winkelman, T. N. A., Zivin, K., Terplan, M., Mhyre, J. M., & Dalton, V. K. (2018b). Racial and ethnic disparities in the incidence of severe maternal morbidity in the United States, 2012–2015. Obstetrics and Gynecology, 132(5), 1158–1166. https://doi.org/10.1097/AOG.0000000000002937.PubMedCrossRef

Arnaudo, C. L., Andraka-Christou, B., & Allgood, K. (2017). Psychiatric co-morbidities in pregnant women with opioid use disorders: Prevalence, impact, and implications for treatment. Current Addiction Reports, 4(1), 1–13. https://doi.org/10.1007/s40429-017-0132-4.PubMedPubMedCentralCrossRef

Bacak, S. J., Callaghan, W. M., Dietz, P. M., & Crouse, C. (2005). Pregnancy-associated hospitalizations in the United States, 1999–2000. American Journal of Obstetrics and Gynecology, 192(2), 592–597. https://doi.org/10.1016/j.ajog.2004.10.638.PubMedCrossRef

Bennett, T. A., Kotelchuck, M., Cox, C. E., Tucker, M. J., & Nadeau, D. A. (1998). Pregnancy-associated hospitalizations in the United States in 1991 and 1992: A comprehensive view of maternal morbidity. American Journal of Obstetrics and Gynecology, 178(2), 346–354.PubMed

Building U.S. Capacity to Review and Prevent Maternal Deaths. (2018). Report from nine maternal mortality review committees. Retrieved March 14, 2019 from http://reviewtoaction.org/Report_from_Nine_MMRCs.

Clemans-Cope, L., Lynch, V., Howell, E., Hill, I., Holla, N., Morgan, J., … Thompson, J. A. (2019). Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016. Drug Alcohol Depend, 195, 156–163. https://doi.org/10.1016/j.drugalcdep.2018.12.005.

East, C. E., Biro, M. A., Fredericks, S., & Lau, R. (2019). Support during pregnancy for women at increased risk of low birthweight babies. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD000198.pub3.PubMedCrossRef

Faherty, L. J., Matone, M., Passarella, M., & Lorch, S. (2018). Mental health of mothers of infants with neonatal abstinence syndrome and prenatal opioid exposure. Maternal and Child Health Journal, 22(6), 841–848. https://doi.org/10.1007/s10995-018-2457-6.PubMedCrossRef

Fitzsimons, H. E., Tuten, M., Vaidya, V., & Jones, H. E. (2007). Mood disorders affect drug treatment success of drug-dependent pregnant women. Journal of Substance Abuse Treatment, 32(1), 19–25. https://doi.org/10.1016/j.jsat.2006.06.015.PubMedCrossRef

Franks, A. L., Kendrick, J. S., Olson, D. R., Atrash, H. K., Saftlas, A. F., & Moien, M. (1992). Hospitalization for pregnancy complications, United States, 1986 and 1987. American Journal of Obstetrics and Gynecology, 166(5), 1339–1344.PubMed

Gazmararian, J. A., Petersen, R., Jamieson, D. J., Schild, L., Adams, M. M., Deshpande, A. D., et al. (2002). Hospitalizations during pregnancy among managed care enrollees. Obstetrics and Gynecology, 100(1), 94–100.PubMed

Haight, S. C., Ko, J., Tong, V. T., Bohm, M. K., & Callaghan, W. M. (2018). Opioid use disorder documented at delivery hospitalization-United States, 1999–2014. Morbidity and Mortality Weekly Report, 67, 845–849. https://doi.org/10.15585/mmwr.mm6731a1.PubMedPubMedCentralCrossRef

HCUP State Inpatient Databases (SID). Healthcare Cost and Utilization Project (HCUP). (2009). Agency for healthcare research and quality. Rockville, MD. https://www.hcup-us.ahrq.gov/sidoverview.jsp.

Holbrook, A., & Kaltenbach, K. (2012). Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression. American Journal of Drug and Alcohol Abuse, 38(6), 575–579. https://doi.org/10.3109/00952990.2012.696168.PubMedCrossRef

Kuklina, E. V., Whiteman, M. K., Hillis, S. D., Jamieson, D. J., Meikle, S. F., Posner, S. F., et al. (2008). An enhanced method for identifying obstetric deliveries: Implications for estimating maternal morbidity. Maternal and Child Health Journal, 12(4), 469–477. https://doi.org/10.1007/s10995-007-0256-6.PubMedCrossRef

Maeda, A., Bateman, B. T., Clancy, C. R., Creanga, A. A., & Leffert, L. R. (2014). Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology, 121(6), 1158–1165. https://doi.org/10.1097/ALN.0000000000000472.PubMedCrossRef

Martin, A. S., Zhang, Y., Crawford, S., Boulet, S. L., McKane, P., Kissin, D. M., … States Monitoring Assisted Reproductive Technology, C. (2016). Antenatal hospitalizations among pregnancies conceived with and without assisted reproductive technology. Obstetrics & Gynecology 127(5), 941-950. https://doi.org/10.1097/AOG.0000000000001392

Molina, R. L., & Pace, L. E. (2017). A renewed focus on maternal health in the United States. New England Journal of Medicine, 377(18), 1705–1707. https://doi.org/10.1056/NEJMp1709473.PubMedCrossRef

Moniz, M. H., Spector-Bagdady, K., Heisler, M., & Harris, L. H. (2017). Inpatient postpartum long-acting reversible contraception: care that promotes reproductive justice. Obstetrics and Gynecology, 130(4), 783–787. https://doi.org/10.1097/AOG.0000000000002262.PubMedPubMedCentralCrossRef

O'Hara, M. W., & McCabe, J. E. (2013). Postpartum depression: current status and future directions. Annual Review of Clinical Psychology, 9, 379–407. https://doi.org/10.1146/annurev-clinpsy-050212-185612.PubMedCrossRef

Patrick, S. W., Buntin, M. B., Martin, P. R., Scott, T. A., Dupont, W., Richards, M., et al. (2018). Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Substance Abuse. https://doi.org/10.1080/08897077.2018.1488336.PubMedPubMedCentralCrossRef

Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA, 307(18), 1934–1940. https://doi.org/10.1001/jama.2012.3951.PubMedCrossRef

Pearson, R. M., Evans, J., Kounali, D., Lewis, G., Heron, J., Ramchandani, P. G., … Stein, A. (2013). Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry, 70(12), 1312-1319. https://doi.org/10.1001/jamapsychiatry.2013.2163

Scott, C. L., Chavez, G. F., Atrash, H. K., Taylor, D. J., Shah, R. S., & Rowley, D. (1997). Hospitalizations for severe complications of pregnancy, 1987–1992. Obstetrics and Gynecology, 90(2), 225–229. https://doi.org/10.1016/S0029-7844(97)00230-5.PubMedCrossRef

Short, V. L., Hand, D. J., MacAfee, L., Abatemarco, D. J., & Terplan, M. (2018). Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States. Journal of Substance Abuse Treatment, 89, 67–74. https://doi.org/10.1016/j.jsat.2018.04.003.PubMedCrossRef

Tronick, E., & Reck, C. (2009). Infants of depressed mothers. Harvard Review of Psychiatry, 17(2), 147–156. https://doi.org/10.1080/10673220902899714.PubMedCrossRef

Tuten, M., Fitzsimons, H., Chisolm, M. S., Jones, H. E., Heil, S. H., & O'Grady, K. E. (2009). The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. American Journal of Drug and Alcohol Abuse, 35(5), 358–363. https://doi.org/10.1080/00952990903108231.PubMedCrossRef

Winkelman, T. N. A., Villapiano, N., Kozhimannil, K. B., Davis, M. M., & Patrick, S. W. (2018). Incidence and costs of neonatal abstinence syndrome among infants with medicaid: 2004–2014. Pediatrics. https://doi.org/10.1542/peds.2017-3520.PubMedPubMedCentralCrossRef

Titel: Antenatal Admissions Among Women with Opioid-Affected and Non-Opioid-Affected Deliveries
verfasst von: Laura J. Faherty
Ashley M. Kranz
Joshua Russell-Fritch
Teague Ruder
Stephen W. Patrick
Bradley D. Stein
Publikationsdatum: 17.06.2020
Verlag: Springer US
Erschienen in: Maternal and Child Health Journal / Ausgabe 9/2020
Print ISSN: 1092-7875
Elektronische ISSN: 1573-6628
DOI: https://doi.org/10.1007/s10995-020-02959-7

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions for Practice

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2020

Pilot Randomized Controlled Trial of an Interconception Intervention Provided by Public Health Nurses

Comparison of Early Life Obesity-Related Risk and Protective Factors in Non-Hispanic Black Subgroups

A Cross-Section Study of Relationship Characteristics and Smoking Cessation During Pregnancy in a Sample of Romanian Pregnant Women

Mobilizing a Public Health Response: Supporting the Perinatal Needs of New Yorkers During the COVID-19 Pandemic

Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity

An Overlooked and More Complicated Association of Social Support with Infant Birth Size: Commentary on Appleton and Colleagues (2019)